Hybrid coronary revascularization

Gadelkarim, Ibrahim; Borger, Michael A.; Davierwala, Piroze

doi:10.21037/amj-20-88

Cited by 1 publication

(3 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…9 Ibrahim et al in their study, had a 2.0% reexploration rate for both MIHCR and OPCABG. 5 It is evident that in our study, the re-exploration rates were lower than those of the MIHCR groups and OPCABG groups, as shown in the review of the literature.…”

Section: Discussionsupporting

confidence: 57%

“…4 Ibrahim et al, in their study, had a 30-day mortality of 2.9% for the OPCABG group and 2.0% for the MIHCR group. 5 Qui et al, in their study, showed a mortality of 2.0% for the OPCABG group and 0.1% for the MIHCR group. As shown above, this study has a 30day mortality similar to that of the various MIHCR studies across the globe.…”

Section: Discussionmentioning

confidence: 86%

“…Ibrahim et al in their study, showed a revascularization rate of 1.0% for OPCABG and 2% for MIHCR groups. 5 In their study, Patel et al showed a revascularization rate of 0.5% for OPCABG and 1.0% for MIHCR. 4 This study showed a similar revascularization rate compared to various MIHCR and OPCABG studies mentioned in review of the literature.…”

Section: Discussionmentioning

confidence: 93%

See 2 more Smart Citations

Early outcomes of minimally invasive hybrid coronary revascularization

Bakthavachalam,

Yusuf

2024

Int Surg J

View full text Add to dashboard Cite

Background: Coronary artery bypass graft (CABG) surgery has been the gold standard for the treatment of coronary artery disease over the years. It is recommended for patients with multi-vessel coronary artery disease, left main disease, diabetics, severe left ventricular dysfunction, unsuitable anatomy for percutaneous coronary intervention (PCI), and failed PCI. The usage of the left internal mammary artery (LIMA) in the CABG to the left anterior descending (LAD) artery has proven to be superior compared to PCI. Minimally invasive hybrid coronary revascularization (MIHCR) is gaining growing interest. Methods: This is a hospital-based prospective observational study with 200 patients followed up for a period of 30 days. This study aims to assess the early outcomes of MIHCR in the Indian population. Results: The 30-day mortality was comparable to other studies, and the number of days in the ICU and hospital stay was shorter than the routine CABG. There was no incidence of a wound infection or stroke. Blood product usage and the need for repeat revascularization and re-exploration were less. The short-term outcomes were promising. Conclusions: MIHCR has excellent short-term results and is safer than conventional OPCABG, as it is less invasive and avoids midline sternotomy. It also reduces the incidence of stroke and lesser usage of blood products, promoting early return of patients to their routine activities.

show abstract

Section: Discussionsupporting

confidence: 57%

Section: Discussionmentioning

confidence: 86%